ArticleJournal of family medicine and primary care2022
Knowledge and awareness of glaucoma in a population of Abha, Southern Saudi Arabia.
Article in Journal of family medicine and primary care, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 9 citations in OpenAlex.
- Knowledge and Awareness of Glaucoma Among Medical Students in Aseer Region, Saudi Arabia.Cureus · 2025Article
- Awareness and Knowledge of Glaucoma Among the Diabetic Population of Saudi Arabia: A Cross-Sectional Study.Cureus · 2024Article
- Investigation of Knowledge, Awareness, and Practices of Glaucoma in Riyadh City, Saudi Arabia.Cureus · 2024Article
- Development of Carvedilol Nanoformulation-Loaded Poloxamer-Based In Situ Gel for the Management of Glaucoma.Gels (Basel, Switzerland) · 2023Article
- Knowledge and Awareness of Glaucoma Among People Living in Taif City in the Western Region of Saudi Arabia.Cureus · 2023Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Glaucoma is a disease that results in a painless elevation of intro ulster pressure (IOP), which can lead to progressive optic nerve damage and visual field loss. According to the World Health Organization (WHO), glaucoma is the second leading cause of irreversible blindness worldwide. It is certain that understanding the disease and knowing the people most susceptible, such as those with chronic diseases such as diabetes and hypertension may help treat the condition and check it regularly to avoid irreversible blindness. Materials and Methods: This study was done to measure the extent of people's awareness and knowledge about glaucoma. The study was cross sectional and used a questionnaire to find about the awareness of glaucoma among the residents of Abha. The sample size was 1563. It was conducted within 2 months of taking ethical approval and informed consent. Data was analyzed by statistical package for the social sciences (SPSS) program, version 22. Results: The study results showed that around 77.1% of the respondents had heard about glaucoma. Of the 1563 participants, the majority were women and they constituted 81.0%. Nearly 88.3% replied that glaucoma may lead to blindness and 86.9% agreed that early screening helps avoid the complications of glaucoma. Although just 5.4% did glaucoma screening, 43.0% concurred that this blindness can be treated. Conclusion: Current research evaluated the awareness and knowledge of glaucoma among the residents of Aseer. Good awareness level regarding glaucoma was found among 725 respondents (46.4%) and 53.6% had poor awareness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.